Is Vaginal Estrogen Safe? What the Research Actually Says

Is Vaginal Estrogen Safe? What the Research Actually Says

Written by Dr. Madeleine Clark, ND MSCP

If you've been told vaginal estrogen could help with dryness, pain, or recurrent UTIs, but you're hesitant because of how "hormones" are usually talked about, you're not alone. This is one of the most common conversations I have in clinic. The short answer: for most people, low-dose vaginal estrogen is considered safe and effective, and it's not the same thing as systemic hormone therapy. Here's what the evidence actually says.

Vaginal Estrogen vs. Systemic HRT: What's the Difference?

A lot of the fear around vaginal estrogen comes from research and warnings that were designed for systemic hormone therapy, the kind that circulates through your whole body. Vaginal estrogen works differently. Low-dose vaginal estrogen delivers estrogen directly to the tissue that needs it, with minimal absorption into the rest of your body. Depending on the formulation, whether it's a ring, tablet, or cream, the amount that reaches your bloodstream stays close to normal postmenopausal levels, even with long-term use.

This distinction matters, because a lot of the safety data that gets cited in conversations about hormone therapy, including increased risk of blood clots, stroke, or heart disease, comes from studies on systemic therapy. Vaginal estrogen hasn't shown that same risk profile.

You Don't Need a Progestogen, and You Don't Need Routine Monitoring

One question I get often: "Don't I need progesterone to protect my uterus if I'm using estrogen?" For systemic hormone therapy, yes. For low-dose vaginal estrogen, the research says no.

A Cochrane review of 19 trials, covering more than 4,000 women, found no increased risk of endometrial hyperplasia with vaginal estrogen compared to placebo. Because of this, a progestogen isn't considered necessary for endometrial protection, and routine endometrial monitoring isn't required either. The one thing that should always prompt a follow-up is any postmenopausal bleeding. That's true regardless of what therapy you're on, and it's worth getting checked.

The FDA Has Updated Its Safety Guidance on Vaginal Estrogen

For years, vaginal estrogen products carried the same boxed warning as systemic hormone therapy, based on older trial data that wasn't actually about vaginal estrogen. That's changed. The FDA has since removed the breast cancer-related boxed warning from vaginal estrogen products, formally recognizing that vaginal estrogen has a different safety profile than systemic therapy. This is a meaningful shift, and it reflects what a lot of the more recent research has been showing for a while.

What About Breast Cancer History?

This is a more layered conversation, and an important one. If you have a personal history of breast cancer, the approach to treating GSM looks a bit different, and there are some specific considerations depending on what treatments you're on. I'm going to cover this in its own post soon, because it deserves a proper, dedicated answer rather than a few lines here. If this applies to you, hold tight, or feel free to book a consult so we can talk through your specific situation directly.

The Bottom Line

For most people without a complicating history, low-dose vaginal estrogen is a well-studied, safe option for treating GSM symptoms like dryness, pain, and recurrent UTIs. The data continues to get stronger, and regulatory guidance is catching up to reflect that. If you've been putting off treatment because of how hormone therapy is talked about in general, it might be worth revisiting with accurate, current information. You don't have to just tough this out.

Dr. Madeleine Clark, ND MSCP, is a naturopathic doctor focusing on perimenopause and hormonal health, and co-founder of Crafted Balance Naturopathic Clinic in Toronto.